Do analysts rate PETV or KEQU?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PetVivo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Kewaunee Scientific 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media prefer PETV or KEQU?

In the previous week, PetVivo and PetVivo both had 4 articles in the media. Kewaunee Scientific's average media sentiment score of 0.45 beat PetVivo's score of 0.00 indicating that Kewaunee Scientific is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PetVivo 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Kewaunee Scientific 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate ECOR or PETV?

electroCore currently has a consensus price target of $18.00, indicating a potential upside of 61.87%. Given electroCore's stronger consensus rating and higher probable upside, equities research analysts clearly believe electroCore is more favorable than PetVivo. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score electroCore 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 PetVivo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is ECOR or PETV more profitable?

electroCore has a net margin of -39.96% compared to PetVivo's net margin of -902.82%. electroCore's return on equity of -1,956.38% beat PetVivo's return on equity. Company Net Margins Return on Equity Return on Assets electroCore -39.96% -1,956.38% -81.35% PetVivo -902.82% -4,813.07% -281.78%

Does the media refer more to ECOR or PETV?

In the previous week, electroCore had 3 more articles in the media than PetVivo. MarketBeat recorded 7 mentions for electroCore and 4 mentions for PetVivo. electroCore's average media sentiment score of 1.21 beat PetVivo's score of 0.00 indicating that electroCore is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment electroCore 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PetVivo 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate NRXS or PETV?

NeurAxis presently has a consensus price target of $13.00, indicating a potential upside of 71.96%. Given NeurAxis' stronger consensus rating and higher probable upside, equities analysts plainly believe NeurAxis is more favorable than PetVivo. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NeurAxis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 PetVivo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable earnings & valuation, NRXS or PETV?

PetVivo has lower revenue, but higher earnings than NeurAxis. NeurAxis is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio NeurAxis $5.32M 17.86 -$14.63M -$0.78 N/A PetVivo $1.05M 30.47 -$10.95M -$0.34 N/A

Is NRXS or PETV more profitable?

NeurAxis has a net margin of -492.76% compared to PetVivo's net margin of -902.82%. NeurAxis' return on equity of 0.00% beat PetVivo's return on equity. Company Net Margins Return on Equity Return on Assets NeurAxis -492.76% N/A -641.25% PetVivo -902.82% -4,813.07% -281.78%

Does the media favor NRXS or PETV?

In the previous week, PetVivo had 3 more articles in the media than NeurAxis. MarketBeat recorded 4 mentions for PetVivo and 1 mentions for NeurAxis. NeurAxis' average media sentiment score of 0.00 equaled PetVivo'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NeurAxis 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral PetVivo 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend PETV or MBOT?

Microbot Medical has a consensus target price of $6.38, suggesting a potential upside of 400.00%. Given Microbot Medical's stronger consensus rating and higher probable upside, analysts plainly believe Microbot Medical is more favorable than PetVivo. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PetVivo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Microbot Medical 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40

Is PETV or MBOT more profitable?

Microbot Medical has a net margin of 0.00% compared to PetVivo's net margin of -902.82%. Microbot Medical's return on equity of -21.87% beat PetVivo's return on equity. Company Net Margins Return on Equity Return on Assets PetVivo -902.82% -4,813.07% -281.78% Microbot Medical N/A -21.87% -20.76%

Does the media prefer PETV or MBOT?

In the previous week, Microbot Medical had 1 more articles in the media than PetVivo. MarketBeat recorded 5 mentions for Microbot Medical and 4 mentions for PetVivo. Microbot Medical's average media sentiment score of 0.69 beat PetVivo's score of 0.00 indicating that Microbot Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PetVivo 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Microbot Medical 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate PETV or LNSR?

LENSAR has a consensus target price of $11.50, indicating a potential upside of 66.18%. Given LENSAR's stronger consensus rating and higher probable upside, analysts clearly believe LENSAR is more favorable than PetVivo. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PetVivo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 LENSAR 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Which has better earnings and valuation, PETV or LNSR?

PetVivo has higher earnings, but lower revenue than LENSAR. LENSAR is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio PetVivo $1.05M 30.47 -$10.95M -$0.34 N/A LENSAR $58.44M 1.46 -$34.28M -$0.33 N/A

Is PETV or LNSR more profitable?

LENSAR has a net margin of 57.57% compared to PetVivo's net margin of -902.82%. LENSAR's return on equity of -529.08% beat PetVivo's return on equity. Company Net Margins Return on Equity Return on Assets PetVivo -902.82% -4,813.07% -281.78% LENSAR 57.57% -529.08% 50.03%

Does the media prefer PETV or LNSR?

In the previous week, PetVivo had 2 more articles in the media than LENSAR. MarketBeat recorded 4 mentions for PetVivo and 2 mentions for LENSAR. LENSAR's average media sentiment score of 0.89 beat PetVivo's score of 0.00 indicating that LENSAR is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PetVivo 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral LENSAR 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

PetVivo (PETV) Competitors

$0.84 0.00 (-0.12%)

As of 09/25/2026 02:52 PM Eastern

Compare

PETV vs. KEQU, ECOR, NRXS, MBOT, and LNSR

Should you buy PetVivo stock or one of its competitors? PetVivo's main competitors and comparable companies include Kewaunee Scientific (KEQU), electroCore (ECOR), NeurAxis (NRXS), Microbot Medical (MBOT), and LENSAR (LNSR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does PetVivo compare to Kewaunee Scientific?

PetVivo (NASDAQ:PETV) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, media sentiment, profitability, risk and earnings.

24.5% of PetVivo shares are held by institutional investors. Comparatively, 32.7% of Kewaunee Scientific shares are held by institutional investors. 10.8% of PetVivo shares are held by insiders. Comparatively, 14.1% of Kewaunee Scientific shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PetVivo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Kewaunee Scientific	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Kewaunee Scientific has higher revenue and earnings than PetVivo. PetVivo is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PetVivo	$1.05M	30.47	-$10.95M	-$0.34	N/A
Kewaunee Scientific	$282M	0.35	$9.62M	$2.76	12.33

PetVivo has a beta of 1.36, indicating that its stock price is 36% more volatile than the broader market. Comparatively, Kewaunee Scientific has a beta of 0.73, indicating that its stock price is 27% less volatile than the broader market.

Kewaunee Scientific has a net margin of 2.97% compared to PetVivo's net margin of -902.82%. Kewaunee Scientific's return on equity of 11.61% beat PetVivo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PetVivo	-902.82%	-4,813.07%	-281.78%
Kewaunee Scientific	2.97%	11.61%	4.82%

In the previous week, PetVivo and PetVivo both had 4 articles in the media. Kewaunee Scientific's average media sentiment score of 0.45 beat PetVivo's score of 0.00 indicating that Kewaunee Scientific is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PetVivo	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Kewaunee Scientific	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Kewaunee Scientific beats PetVivo on 11 of the 13 factors compared between the two stocks.

How does PetVivo compare to electroCore?

electroCore (NASDAQ:ECOR) and PetVivo (NASDAQ:PETV) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, risk, profitability, earnings, dividends, analyst recommendations, valuation and institutional ownership.

electroCore has a net margin of -39.96% compared to PetVivo's net margin of -902.82%. electroCore's return on equity of -1,956.38% beat PetVivo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
electroCore	-39.96%	-1,956.38%	-81.35%
PetVivo	-902.82%	-4,813.07%	-281.78%

26.7% of electroCore shares are owned by institutional investors. Comparatively, 24.5% of PetVivo shares are owned by institutional investors. 7.8% of electroCore shares are owned by insiders. Comparatively, 10.8% of PetVivo shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

electroCore currently has a consensus price target of $18.00, indicating a potential upside of 61.87%. Given electroCore's stronger consensus rating and higher probable upside, equities research analysts clearly believe electroCore is more favorable than PetVivo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
electroCore	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
PetVivo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, electroCore had 3 more articles in the media than PetVivo. MarketBeat recorded 7 mentions for electroCore and 4 mentions for PetVivo. electroCore's average media sentiment score of 1.21 beat PetVivo's score of 0.00 indicating that electroCore is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
electroCore	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PetVivo	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

PetVivo has lower revenue, but higher earnings than electroCore. electroCore is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
electroCore	$32.03M	3.13	-$13.97M	-$1.66	N/A
PetVivo	$1.05M	30.47	-$10.95M	-$0.34	N/A

electroCore has a beta of 1, suggesting that its stock price has a similar volatility profile to the broader market.Comparatively, PetVivo has a beta of 1.36, suggesting that its stock price is 36% more volatile than the broader market.

Summary

electroCore beats PetVivo on 10 of the 16 factors compared between the two stocks.

How does PetVivo compare to NeurAxis?

NeurAxis (NASDAQ:NRXS) and PetVivo (NASDAQ:PETV) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, earnings, risk, valuation, institutional ownership, media sentiment, dividends and analyst recommendations.

11.8% of NeurAxis shares are owned by institutional investors. Comparatively, 24.5% of PetVivo shares are owned by institutional investors. 21.1% of NeurAxis shares are owned by company insiders. Comparatively, 10.8% of PetVivo shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

NeurAxis has a beta of 1.47, indicating that its stock price is 47% more volatile than the broader market. Comparatively, PetVivo has a beta of 1.36, indicating that its stock price is 36% more volatile than the broader market.

NeurAxis presently has a consensus price target of $13.00, indicating a potential upside of 71.96%. Given NeurAxis' stronger consensus rating and higher probable upside, equities analysts plainly believe NeurAxis is more favorable than PetVivo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeurAxis	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
PetVivo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, PetVivo had 3 more articles in the media than NeurAxis. MarketBeat recorded 4 mentions for PetVivo and 1 mentions for NeurAxis. NeurAxis' average media sentiment score of 0.00 equaled PetVivo'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NeurAxis	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
PetVivo	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

PetVivo has lower revenue, but higher earnings than NeurAxis. NeurAxis is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeurAxis	$5.32M	17.86	-$14.63M	-$0.78	N/A
PetVivo	$1.05M	30.47	-$10.95M	-$0.34	N/A

NeurAxis has a net margin of -492.76% compared to PetVivo's net margin of -902.82%. NeurAxis' return on equity of 0.00% beat PetVivo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NeurAxis	-492.76%	N/A	-641.25%
PetVivo	-902.82%	-4,813.07%	-281.78%

Summary

NeurAxis beats PetVivo on 8 of the 15 factors compared between the two stocks.

How does PetVivo compare to Microbot Medical?

PetVivo (NASDAQ:PETV) and Microbot Medical (NASDAQ:MBOT) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, earnings, dividends, risk, valuation and media sentiment.

24.5% of PetVivo shares are owned by institutional investors. Comparatively, 16.3% of Microbot Medical shares are owned by institutional investors. 10.8% of PetVivo shares are owned by company insiders. Comparatively, 4.7% of Microbot Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Microbot Medical had 1 more articles in the media than PetVivo. MarketBeat recorded 5 mentions for Microbot Medical and 4 mentions for PetVivo. Microbot Medical's average media sentiment score of 0.69 beat PetVivo's score of 0.00 indicating that Microbot Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PetVivo	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Microbot Medical	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Microbot Medical has a consensus target price of $6.38, suggesting a potential upside of 400.00%. Given Microbot Medical's stronger consensus rating and higher probable upside, analysts plainly believe Microbot Medical is more favorable than PetVivo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PetVivo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Microbot Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

PetVivo has a beta of 1.36, meaning that its stock price is 36% more volatile than the broader market. Comparatively, Microbot Medical has a beta of 1.03, meaning that its stock price is 3% more volatile than the broader market.

PetVivo has higher revenue and earnings than Microbot Medical. Microbot Medical is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PetVivo	$1.05M	30.47	-$10.95M	-$0.34	N/A
Microbot Medical	N/A	N/A	-$13.14M	-$0.24	N/A

Microbot Medical has a net margin of 0.00% compared to PetVivo's net margin of -902.82%. Microbot Medical's return on equity of -21.87% beat PetVivo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PetVivo	-902.82%	-4,813.07%	-281.78%
Microbot Medical	N/A	-21.87%	-20.76%

Summary

Microbot Medical beats PetVivo on 9 of the 15 factors compared between the two stocks.

How does PetVivo compare to LENSAR?

PetVivo (NASDAQ:PETV) and LENSAR (NASDAQ:LNSR) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, dividends, media sentiment and valuation.

LENSAR has a consensus target price of $11.50, indicating a potential upside of 66.18%. Given LENSAR's stronger consensus rating and higher probable upside, analysts clearly believe LENSAR is more favorable than PetVivo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PetVivo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
LENSAR	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

LENSAR has a net margin of 57.57% compared to PetVivo's net margin of -902.82%. LENSAR's return on equity of -529.08% beat PetVivo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PetVivo	-902.82%	-4,813.07%	-281.78%
LENSAR	57.57%	-529.08%	50.03%

24.5% of PetVivo shares are owned by institutional investors. Comparatively, 40.2% of LENSAR shares are owned by institutional investors. 10.8% of PetVivo shares are owned by company insiders. Comparatively, 65.8% of LENSAR shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

PetVivo has higher earnings, but lower revenue than LENSAR. LENSAR is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PetVivo	$1.05M	30.47	-$10.95M	-$0.34	N/A
LENSAR	$58.44M	1.46	-$34.28M	-$0.33	N/A

In the previous week, PetVivo had 2 more articles in the media than LENSAR. MarketBeat recorded 4 mentions for PetVivo and 2 mentions for LENSAR. LENSAR's average media sentiment score of 0.89 beat PetVivo's score of 0.00 indicating that LENSAR is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PetVivo	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
LENSAR	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

PetVivo has a beta of 1.36, indicating that its stock price is 36% more volatile than the broader market. Comparatively, LENSAR has a beta of 0.97, indicating that its stock price is 3% less volatile than the broader market.

Summary

LENSAR beats PetVivo on 11 of the 16 factors compared between the two stocks.

Get PetVivo News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PETV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PETV vs. The Competition

Export

Metric	PetVivo	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$31.87M	$5.60B	$7.35B	$13.18B
Dividend Yield	N/A	1.79%	2.52%	14.03%
P/E Ratio	-1.86	21.02	215.02	21.21
Price / Sales	30.47	72.02	617.13	84.93
Price / Cash	N/A	33.37	28.02	35.00
Price / Book	-27.97	5.97	10.48	6.36
Net Income	-$10.95M	$151.55M	$3.51B	$360.40M
7 Day Performance	7.17%	-0.97%	-1.31%	-0.23%
1 Month Performance	23.38%	-4.40%	-4.61%	-4.16%
1 Year Performance	-16.10%	7.68%	15.01%	4.58%

PetVivo Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PETV PetVivo	N/A	$0.84 -0.1%	N/A	-16.1%	$31.87M	$1.05M	N/A	20	News Coverage
KEQU Kewaunee Scientific	0.7122 of 5 stars	$34.11 -5.5%	N/A	-22.2%	$104.55M	$282M	12.36	1,231	Gap Down High Trading Volume
ECOR electroCore	3.3204 of 5 stars	$11.68 +2.6%	$18.00 +54.1%	+125.6%	$102.60M	$32.03M	N/A	83	News Coverage
NRXS NeurAxis	1.2458 of 5 stars	$7.61 -0.3%	$13.00 +70.8%	+152.8%	$95.57M	$5.32M	N/A	24
MBOT Microbot Medical	2.4277 of 5 stars	$1.36 -4.2%	$6.38 +368.8%	-60.4%	$95.37M	N/A	N/A	22	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PETV) was last updated on 9/27/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

PetVivo (PETV) Competitors

PETV vs. KEQU, ECOR, NRXS, MBOT, and LNSR

How does PetVivo compare to Kewaunee Scientific?

Summary

How does PetVivo compare to electroCore?

Summary

How does PetVivo compare to NeurAxis?

Summary

How does PetVivo compare to Microbot Medical?

Summary

How does PetVivo compare to LENSAR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PETV vs. The Competition

PetVivo Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

PetVivo (PETV) Competitors

PETV vs. KEQU, ECOR, NRXS, MBOT, and LNSR

How does PetVivo compare to Kewaunee Scientific?

Do insiders & institutionals hold more shares of PETV or KEQU?

Do analysts rate PETV or KEQU?

Which has better earnings and valuation, PETV or KEQU?

Which has more volatility & risk, PETV or KEQU?

Is PETV or KEQU more profitable?

Does the media prefer PETV or KEQU?

Summary

How does PetVivo compare to electroCore?

Is ECOR or PETV more profitable?

Do institutionals and insiders believe in ECOR or PETV?

Do analysts rate ECOR or PETV?

Does the media refer more to ECOR or PETV?

Which has preferable valuation & earnings, ECOR or PETV?

Which has more volatility and risk, ECOR or PETV?

Summary

How does PetVivo compare to NeurAxis?

Do insiders & institutionals have more ownership in NRXS or PETV?

Which has more risk and volatility, NRXS or PETV?

Do analysts rate NRXS or PETV?

Does the media favor NRXS or PETV?

Which has preferable earnings & valuation, NRXS or PETV?

Is NRXS or PETV more profitable?

Summary

How does PetVivo compare to Microbot Medical?

Do insiders & institutionals hold more shares of PETV or MBOT?

Does the media prefer PETV or MBOT?

Do analysts recommend PETV or MBOT?

Which has more volatility & risk, PETV or MBOT?

Which has stronger earnings & valuation, PETV or MBOT?

Is PETV or MBOT more profitable?

Summary

How does PetVivo compare to LENSAR?

Do analysts rate PETV or LNSR?

Is PETV or LNSR more profitable?

Do institutionals & insiders believe in PETV or LNSR?

Which has better earnings and valuation, PETV or LNSR?

Does the media prefer PETV or LNSR?

Which has more risk and volatility, PETV or LNSR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PETV vs. The Competition

PetVivo Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools